Latest Radiology / Nuclear Medicine News From Medical News Today.

Task Force Develops New Radiation Guidelines For Brachytherapy

Radiation dose delivered to the prostate and nearby organs in every brachytherapy procedure should be carefully analyzed using post-implant CT or MRI and uniformly documented in every patient, according to a new guideline co-authored by Yan Yu, Ph.D., director of Medical Physics in the department of Radiation Oncology at Thomas Jefferson University.

The Benefits And Risks Of Preventative Brain Radiation For Lung Cancer Patients

A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain. Study results show that while preventative brain radiation for patients with non-small cell lung cancer - the most common form of lung cancer - does reduce the chance of developing brain metastases, it impacts some short-term and long-term memory.

Treating Breast Cancer With Adapted Space-Industry Technology

Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a study to determine if an imaging technique used by NASA to inspect the space shuttle can be used to predict tissue damage often experienced by breast cancer patients undergoing radiation therapy. The study is examining the utility of three-dimensional thermal tomography in radiation oncology.

Improved Healing Of Bone Fractures After Radiation Exposure

A drug currently under development by the University of Pittsburgh School of Medicine may help bone fractures heal more quickly after radiation exposure, according to a study by Pitt researchers. The study's results were presented during the American Society for Radiation Oncology (ASTRO) annual meeting in Chicago. The drug, JP4-039, is a free-radical scavenger targeted to the mitochondria, the energy generator of all cells.

Undetectable PSA After Radiation Is Possible And Predicts Good Patient Outcomes

Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured. The data was presented at the annual meeting of the American Society for Radiation Oncology.

Category: Regulation Issues

More Feeds